M&A Deal Summary |
|
|---|---|
| Date | 2020-12-18 |
| Target | Microbiome Labs |
| Sector | Medical Products |
| Buyer(s) | Novozymes |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1925 |
| Sector | Life Science |
| Employees | 6,397 |
| Revenue | 17.9B DKK (2023) |
Novozymes produces a wide range of industrial enzymes and microorganisms, providing innovative answers to some of the world’s most pressing challenges. Company innovative biological solutions improve industrial manufacturing processes by saving energy, water and raw materials, while reducing waste and emissions, and helping make everyday products more sustainable. Novozymes was founded in 1925 and is based in Bagsvaerd, Denmark.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 10 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 8 of 8 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 4 of 4 |
| Year: 2020 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-25 |
PrecisionBiotics Group
Cork, Florida, Ireland PrecisionBiotics is an innovative Irish healthcare company and a global pioneer in the discovery, development, and commercialization of proprietary probiotic and pharmabiotic treatments. Its new and breakthrough scientific research is recognized around the world as being at the cutting edge of discovery and application. Alimentary Health, the research function of PB, is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland. |
Buy | €80M |
